Search results
Adma Biologics (ADMA) Increases Despite Market Slip: Here's What You Need to Know
Zacks· 4 days agoFree Report) closed the latest trading day at $10.71, indicating a +0.85% change from the previous session's end. The stock's performance was ahead of the S&P 500's daily loss of 0.25%. In that ...
ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Could Be 36% Below Their Intrinsic Value Estimate
Simply Wall St. via Yahoo Finance· 7 days agoKey Insights The projected fair value for ADMA Biologics is US$16.66 based on 2 Stage Free Cash Flow...
As Small Caps Strengthen, I'm Eyeing This Stock
TheStreet.com· 4 days agoTime for an update on ADMA Biologics.
Peeling Back The Layers: Exploring ADMA Biologics Through Analyst Insights - ADMA Biologics (NASDAQ:...
Benzinga· 4 days agoLoading... Loading... 6 analysts have shared their evaluations of ADMA Biologics ADMA during the recent three months, expressing a mix ...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 3 days agoIn terms of fundamental and technical metrics, the best biotech stocks trading above 10 right now...
Intra-Cellular Therapies Stock Scores RS Rating Upgrade To 87
Investor's Business Daily· 4 days agoThe Relative Strength (RS) Rating for Intra-Cellular Therapies stock entered a new percentile...
Arcellx Stock Earns Relative Strength Rating Upgrade
Investor's Business Daily· 3 days agoOne important metric to look for in a stock is an 80 or higher Relative Strength Rating. Arcellx stock cleared that benchmark Friday, with a jump from 79...